The microbial origins of food allergy
- PMID: 33347905
- PMCID: PMC8096615
- DOI: 10.1016/j.jaci.2020.12.624
The microbial origins of food allergy
Abstract
Food allergy (FA) is a significant public health issue, propelled by its rapidly increasing prevalence. Its sharp rise into prominence has focused attention on causative environmental factors and their interplay with the immune system in disease pathogenesis. In that regard, there is now substantial evidence that alterations in the gut microbiome early in life imprint the host gut mucosal immunity and may play a critical role in precipitating FA. These changes may impact key steps in the development of the infant gut microbiome, including its shaping by maternal factors and upon the introduction of solid food (the weaning reaction). These early-life changes may have long-range effects on host immunity that manifest later in time as disease pathology. Experimental studies have shown that resetting the host intestinal immune responses by treatment with either a healthy fecal microbiota transplantation or defined commensal bacterial taxa can prevent or treat FA. The mechanisms by which these interventions suppress FA include restoration of gut immune regulatory checkpoints, notably the retinoic orphan receptor gamma T+ regulatory T cells, the epithelial barrier, and healthy immunoglobulin A responses to the gut commensals. These findings inform human studies currently in progress that evaluate the role of microbial therapies in FA.
Keywords: Food allergy; IgA; IgE; RORγt(+) Treg; dysbiosis; fecal microbiota transplantation; microbiome; microbiota; regulatory T cells.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest Disclosure
R.R. and T.A.C. is an inventor on published US patent application, 15/801,811, that covers methods and compositions for the prevention and treatment of FA using microbial treatments. R.R., E.S.-V. and T.A.C. have pending patent applications related to the use of probiotics in enforcing oral tolerance in FA (62/758,161, and, 62/823,866). T.A.C. is a co-founders of and has equity in ParetoBio. R.R. has equity in ParetoBio.
Figures


Similar articles
-
Pathogenic mechanisms in the evolution of food allergy.Immunol Rev. 2024 Sep;326(1):219-226. doi: 10.1111/imr.13398. Epub 2024 Sep 17. Immunol Rev. 2024. PMID: 39285835 Free PMC article. Review.
-
Dietary and Microbial Determinants in Food Allergy.Immunity. 2020 Aug 18;53(2):277-289. doi: 10.1016/j.immuni.2020.07.025. Immunity. 2020. PMID: 32814026 Free PMC article. Review.
-
Food allergy and the microbiome: Current understandings and future directions.J Allergy Clin Immunol. 2019 Dec;144(6):1468-1477. doi: 10.1016/j.jaci.2019.10.019. J Allergy Clin Immunol. 2019. PMID: 31812181 Free PMC article. Review.
-
Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy.Nat Med. 2019 Jul;25(7):1164-1174. doi: 10.1038/s41591-019-0461-z. Epub 2019 Jun 24. Nat Med. 2019. PMID: 31235962 Free PMC article.
-
Demystifying Dysbiosis: Can the Gut Microbiome Promote Oral Tolerance Over IgE-mediated Food Allergy?Curr Pediatr Rev. 2018;14(3):156-163. doi: 10.2174/1573396314666180507120424. Curr Pediatr Rev. 2018. PMID: 29732975 Review.
Cited by
-
A Combined Analysis of Gut and Skin Microbiota in Infants with Food Allergy and Atopic Dermatitis: A Pilot Study.Nutrients. 2021 May 15;13(5):1682. doi: 10.3390/nu13051682. Nutrients. 2021. PMID: 34063398 Free PMC article.
-
Targeting type 2 immunity and the future of food allergy treatment.J Exp Med. 2023 Apr 3;220(4):e20221104. doi: 10.1084/jem.20221104. Epub 2023 Mar 3. J Exp Med. 2023. PMID: 36880703 Free PMC article. Review.
-
Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development.J Allergy Clin Immunol. 2023 Dec;152(6):1569-1580. doi: 10.1016/j.jaci.2023.08.012. Epub 2023 Aug 22. J Allergy Clin Immunol. 2023. PMID: 37619819 Free PMC article.
-
Pathogenic mechanisms in the evolution of food allergy.Immunol Rev. 2024 Sep;326(1):219-226. doi: 10.1111/imr.13398. Epub 2024 Sep 17. Immunol Rev. 2024. PMID: 39285835 Free PMC article. Review.
-
RELMβ sets the threshold for microbiome-dependent oral tolerance.Nature. 2025 Feb;638(8051):760-768. doi: 10.1038/s41586-024-08440-7. Epub 2025 Jan 22. Nature. 2025. PMID: 39843735 Free PMC article.
References
-
- Sicherer SH, Sampson HA. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol 2018; 141:41–58. - PubMed
-
- Huang YJ, Marsland BJ, Bunyavanich S, O’Mahony L, Leung DY, Muraro A, et al. The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol 2017; 139:1099–110. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous